Contract 75A50124C00004
Zeeva Therapeutics Corporation · Department Of Health And Human Services · August 5, 2024
Zeeva Therapeutics Corporation was awarded a federal contract by Department Of Health And Human Services (Office Of Assistant Secretary For Preparedness And Response) on August 5, 2024 for $742,000 (current value) of work in research and development in biotechnology (except nanobiotechnology). Performance is in Alpharetta, GA. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $742,000.
Contract details
- PIID
- 75A50124C00004
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Full And Open Competition
- NAICS
- 541714 · Research And Development In Biotechnology (Except Nanobiotechnology)
- Product / service
- Health R&D Services; Health Care Services; Experimental Development
- Place of performance
- Alpharetta, GA
- First action
- August 5, 2024
Description
ZEEVA THERAPEUTICS CORPORATION - RESEARCH AND DEVELOPMENT AOI #19 FOR THE DEVELOPMENT OF A NOVEL TUBE JUNCTION CONNECTOR FOR BLOOD CIRCUITS IN ECMO
Modification timeline
-
August 5, 2024Mod P00001 · Supplemental Agreement For Work Within Scope$742.1K
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Battelle Memorial Institute | Department Of Health And Human Services | July 2, 2026 | $6.28M |
| Glaxosmithkline, Llc | Department Of Health And Human Services | July 2, 2026 | $597.8K |
| Medigen, Inc. | Department Of Health And Human Services | July 2, 2026 | $2.18M |
| American Type Culture Collection | Department Of Health And Human Services | July 1, 2026 | $855.4K |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $11.71M |
| Battelle Memorial Institute | Department Of Health And Human Services | July 1, 2026 | $3.49M |
Top contractors in NAICS 541714
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Amgen USA Inc | 1 | $59.99M |
| 2 | Vericel Corporation | 1 | $34.88M |
| 3 | Spectral Md, Inc. | 1 | $31.67M |
| 4 | Ppd Development Lp | 6 | $31.12M |
| 5 | L3 Technologies, Inc. | 1 | $22.00M |
| 6 | Technical Resources International, Inc. | 6 | $21.80M |
| 7 | Abbott Laboratories | 1 | $21.01M |
| 8 | Paratek Pharmaceuticals, Inc | 1 | $17.47M |
| 9 | Ossium Health, Inc. | 1 | $12.39M |
| 10 | Rho Federal Systems Division Inc | 1 | $8.00M |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract 75A50124C00004?
Contract 75A50124C00004 is a federal contract awarded to Zeeva Therapeutics Corporation by Department Of Health And Human Services on August 5, 2024 for $742,000 of work classified under RESEARCH AND DEVELOPMENT IN BIOTECHNOLOGY (EXCEPT NANOBIOTECHNOLOGY). It has been modified 0 times since the base award.
Who won contract 75A50124C00004?
Zeeva Therapeutics Corporation won contract 75A50124C00004 from Department Of Health And Human Services.
How much is contract 75A50124C00004 worth?
Contract 75A50124C00004 has obligated $0 to date but carries a potential ceiling of $742,000 if fully funded and all options are exercised.